Lanean...
Quantitative [(18)F]-FMISO- PET imaging shows reduction of hypoxia following trastuzumab in a murine model of HER2+ breast cancer
PURPOSE: Evaluation of [(18)F]-FMISO-PET imaging as a metric for evaluating early response to trastuzumab therapy with histological validation in a murine model of HER2+ breast cancer. PROCEDURES: Mice with BT474, HER2+ tumors, were imaged with [(18)F]-FMISO-PET during trastuzumab therapy. Pimonidaz...
Gorde:
| Argitaratua izan da: | Mol Imaging Biol |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5214951/ https://ncbi.nlm.nih.gov/pubmed/27506906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-016-0994-1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|